Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rockville, MD
NPI
1124259353
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
932 Hungerford Dr, 9a
Rockville, MD, 20850
Phone (301) 251-0876
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
2,191 services
Medicare patients, 2024
521
Average age 76
Drug cost, 2024
$3.1M
5,326 prescriptions
Company payments, 2025
$4,741
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jie He was code 99214 (office e&m - established), 1,064 times for 443 patients. In total Jie He billed 2,191 services in 10 codes, and Medicare paid $173K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,064 | 443 | $99.60 | $106K |
| 95251 Test - Miscellaneous | Office | 325 | 126 | $28.19 | $9,163 |
| 93922 Duplex Scan - Extremity Arteries | Office | 216 | 214 | $70.07 | $15K |
| 99213 Office E&M - Established | Office | 213 | 121 | $71.26 | $15K |
| 96401 Chemotherapy Administration | Office | 184 | 103 | $59.53 | $11K |
| 99204 Office E&M - New | Office | 88 | 88 | $130.09 | $11K |
| 99203 Office E&M - New | Office | 19 | 19 | $92.01 | $1,748 |
| 95250 Test - Miscellaneous | Office | 17 | 17 | $132.67 | $2,255 |
By year: 2022 $160K for 1,923 services; 2023 $173K for 2,249 services; 2024 $173K for 2,191 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jie He prescribed most often to Medicare patients was Metformin Hcl, with 427 prescriptions and refills. In total Jie He wrote 5,326 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 427 | 900 | 105 | $3,355 |
| Trulicity Dulaglutide | 420 | 575 | 66 | $559K |
| Tresiba Flextouch U-200 Insulin Degludec | 357 | 724 | 79 | $319K |
| Tradjenta Linagliptin | 284 | 333 | 33 | $172K |
| Jardiance Empagliflozin | 226 | 461 | 60 | $260K |
| Ozempic Semaglutide | 208 | 411 | 50 | $379K |
| Prolia Denosumab | 198 | 1,185 | 108 | $338K |
| Mounjaro Tirzepatide | 176 | 230 | 38 | $235K |
| Acarbose Generic | 174 | 291 | 28 | $9,246 |
| Unithroid Levothyroxine Sodium | 157 | 368 | 43 | $6,310 |
| Glipizide Generic | 140 | 270 | 35 | $930 |
| Synthroid Levothyroxine Sodium | 137 | 242 | 26 | $9,883 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 132 | 367 | 52 | $16K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 119 | 183 | 25 | $7,500 |
| Levothyroxine Sodium Generic | 112 | 269 | 32 | $1,127 |
Brand drugs: 3,123 claims; generic drugs: 1,667 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jie He $4,741 ($4,741 in general payments such as food, travel and fees) from 29 companies. The largest payer was Novo Nordisk Inc with $727.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $727 |
| Lilly USA, LLC LLY | 14 | $354 |
| Insulet Corporation PODD | 9 | $344 |
| Amneal Pharmaceuticals LLC AMRX | 17 | $338 |
| Madrigal Pharmaceuticals MDGL | 4 | $304 |
| Corcept Therapeutics CORT | 8 | $286 |
| Dexcom, Inc. DXCM | 5 | $253 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $246 |
| Abbvie Inc. ABBV | 13 | $231 |
| Amgen Inc. AMGN | 10 | $182 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.